Tumor Sequencing
Showing 1 - 25 of >10,000
Circulating Tumor DNA Sequencing in Peripheral T-cell Lymphomas
Not yet recruiting
- Peripheral T Cell Lymphoma
- circulating tumoral DNA detection
-
Rouen, FranceCentre Henri Becquerel
Oct 13, 2023
ful Mutations in Solid Tumor Characterized by Next Generation
Recruiting
- Solid Tumor
- +13 more
-
Aviano, Pordonone, ItalyIRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Sep 8, 2023
Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)
Not yet recruiting
- Hepatocellular Carcinoma
- Colorectal Cancer
- Patient-Derived Tumor Organoids
-
Hong Kong, N.t., Hong KongEndoscopy Centre, Prince of Wales Hospital
Oct 12, 2023
ctDNA Methylation Sequencing for Myeloma
Recruiting
- Multiple Myeloma
- plasma circulation DNA methylation sequencing
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
Oct 11, 2022
Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)
Terminated
- Neuroblastoma
- Cancer
- Biopsy
- +12 more
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jan 31, 2023
Exome/ Genome Sequencing, Conventional Methods in Rare Diseases
Recruiting
- Rare Diseases
- Genetic Predisposition
- Retrospective data analysis
-
Tübingen, GermanyUniversity Hospital Tübingen
Nov 3, 2022
Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)
Completed
- Waldenstrom's Macroglobulinemia
-
Boston, Massachusetts
- +1 more
Dec 5, 2022
Sebaceous Cell Tumor of Eyelid Trial in Roma (exome sequencing (retrospective) and exome and methylome sequencing (prospective))
Recruiting
- Sebaceous Cell Tumor of Eyelid
- exome sequencing (retrospective) and exome and methylome sequencing (prospective)
-
Roma, Rome, ItalyGustavo Savino
Oct 8, 2023
Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole
Recruiting
- Triple Negative Breast Cancer
- +3 more
- Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 15, 2023
Molecular Study and Precision Medicine for Colorectal Cancer
Not yet recruiting
- Advanced Colorectal Carcinoma
- Recurrent Colorectal Carcinoma
- Molecular Profiling & drug testing in tumor organoids and PDXs
-
Wuhan, Hubei, ChinaWuhan Union Hospital, China
May 30, 2023
Head Neck Cancer Trial in Stockholm (DNA exome sequencing of tumor and blood)
Recruiting
- Head and Neck Cancer
- DNA exome sequencing of tumor and blood
-
Stockholm, SwedenKarolinska universitetssjukhuset
Oct 17, 2023
Precision Medicine for Every Child With Cancer
Recruiting
- Childhood Cancer
- +5 more
- Whole Genome Sequencing
- +6 more
-
Adelaide, Australia
- +8 more
Jan 24, 2023
Liquid Biopsy Using Methylation Sequencing for Lung Cancer
Completed
- Lung Cancer
- Diagnoses Disease
- Circulating Tumor DNA Methylation Sequencing
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 5, 2022
Blood and Tumor Samples From Advanced or Metastatic Estrogen
Active, not recruiting
- Advanced Breast Carcinoma
- +8 more
- Biopsy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 3, 2023
Tumor Molecular Profiling in Patients With Prostate Cancer
Completed
- Prostate Cancer
- Metastatic Prostate Adenocarcinoma
- Tumor molecular profiling
-
Athens, GreeceHellenic Cooperative Oncology Group
Oct 17, 2022
ATM Alterations by Next-Generation Sequencing and ATM
Completed
- Solid Tumor, Unspecified, Adult
- Determination of ATM alteration status.
-
Oklahoma City, Oklahoma
- +2 more
Jul 29, 2022
Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation
Not yet recruiting
- Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes)
- Minimal documentation
- Extended documentation
-
Mannheim, Baden-Württemberg, Germany
- +1 more
Jan 18, 2023
Metastatic Breast Cancer Trial in Seoul (Pembrolizumab)
Not yet recruiting
- Metastatic Breast Cancer
-
Seoul, Korea, Republic ofYonsei Cancer Center at Yonsei University Health System
Mar 14, 2022
Hepatocellular Carcinoma Trial in Nanjing (Surufatinib)
Recruiting
- Hepatocellular Carcinoma
-
Nanjing, Jiangsu, ChinaNanjing Drum tower hospital
Apr 6, 2022
Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate
Recruiting
- Metastatic Prostate Cancer
- Liquid Biopsy
- Archival Tumor DNA sequencing
-
Barcelona, SpainSOLTI Cancer Research Group
May 22, 2023
Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil
Recruiting
- Colon Cancer
- +4 more
- 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 15, 2022
Hepatocellular Carcinoma, Circulating Tumor Cell, Whole Genome Sequencing Trial in Chongqing
Recruiting
- Hepatocellular Carcinoma
- +2 more
-
Chongqing, Chinathe second affiliated hospital of Chongqing Medical University
Feb 7, 2022
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk
Recruiting
- Early-Stage Breast Cancer
- Neoadjuvant Therapy
- Genomic Profiling / Sequencing
-
Berlin, Germany
- +4 more
Jun 19, 2023
Solid Tumor, Lymphoma, Multiple Myeloma Trial in Winston-Salem (drug, other, diagnostic test)
Recruiting
- Solid Tumor
- +4 more
- Investigational Agent
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Mar 4, 2022
CATCH: Implementation of Genomics-guided Precision Medicine in
Recruiting
- Metastatic Breast Cancer
- Genomic Profiling / Sequencing
-
Berlin, Germany
- +4 more
Dec 7, 2022